SPIRIVA® Respimat® in asthma

Everything you need to know about using SPIRIVA® Respimat® for your adult asthma patients who remain symptomatic on ICS/LABA

Product information

This section describes the mechanism of action (MoA) of SPIRIVA® Respimat®, and provides information about its efficacy and safety as well as instructions about dosing & administration via the Respimat.


Frequently Asked Questions cover a wide range of subjects including evidence from the SPIRIVA® Respimat® clinical trial programme, prescribing guidelines for SPIRIVA® and the administration of SPIRIVA® via the Respimat® inhaler.

Resource library

The library offers information for healthcare professionals to use directly and to share with patients. Prescribing information for SPIRIVA® Respimat® and a range of clinical cases are presented.